This Cathie Wood ' s Play Just Hit A 7-Month High On A Rival ' s News

stock surged to a seven-month high Tuesday after the company's colon cancer-screening rival, Freenome, unveiled the results of a pivotal study. Freenome is working on a blood-based test to detect colorectal cancer. Overall, Freenome's test proved roughly as specific as Exact Sciences' stool-based…#freenome #exactsciences #isi #vijaykumar #guardanthealth #cathiewood #arkinnovation #evercore #shield #whereexactsciences
Source: Reuters: Health - Category: Consumer Health News Source Type: news